NESS ZIONA, Israel--(BUSINESS WIRE)--Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three and nine months ended September 30, 2015.
Financial highlights of the 2015 third quarter included:
• Total revenues of $16.1 million compared with $17.2 million for the third quarter of 2014;
Help employers find you! Check out all the jobs and post your resume.
